首页> Canadian journal of diabetes> CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice.

CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice.

导出 LinkOut

翻译打印收藏纠错

第一作者： Vincent,Woo

第一单位： University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: Vwoo3@shaw.ca.

作者： Vincent,Woo ^[1] ; Alan,Bell ^[2] ; Maureen,Clement ^[3] ; Luis,Noronha ^[4] ; Michael A,Tsoukas ^[5] ; Fernando,Camacho ^[6] ; Shana,Traina ^[7] ; Natasha,Georgijev ^[8] ; Jennifer B,Rose ^[8] ; Delna,Sorabji ^[8] ; Harpreet S,Bajaj ^[9]

作者单位： University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: Vwoo3@shaw.ca. ^[1] University of Toronto, Toronto, Ontario, Canada. ^[2] University of British Columbia, Vancouver, British Columbia, Canada. ^[3] Diabetes Heart Research Center, Toronto, Ontario, Canada. ^[4] McGill University Health Centre, Montreal, Quebec, Canada. ^[5] University of Waterloo, Waterloo, Ontario, Canada. ^[6] Janssen Global Services, LLC, Raritan, New Jersey, United States. ^[7] Janssen Inc, Toronto, Ontario, Canada. ^[8] LMC Diabetes & Endocrinology, Brampton, Ontario, Canada. ^[9]

关键词 canagliflozin canagliflozine diabète de type 2 health satisfaction patient-reported outcomes résultats rapportés par les patients satisfaction à l'égard de la santé satisfaction à l'égard du poids type 2 diabetes weight satisfaction